• Partnership Improves Scalable Culture Solutions

News & Views

Partnership Improves Scalable Culture Solutions

Oct 19 2018

Under a collaborative agreement, Sartorius Stedim Biotech (SSB) is to integrate Repligen’s ATF cell retention control technology into its large-scale single-use bioreactors providing a single control system for 50 L to 2,000 L bioreactors used in perfusion cell culture applications. SSB’s recently launched single-use mini bioreactor system will also be equipped with Repligen’s hollow fiber filter technology.

“Sartorius Stedim Biotech has continuously expanded its integrated upstream portfolio over the past years with a focus on robust and scalable, automated single-use solutions, optimised for high-cell-density applications. The collaboration with Repligen will result in easy-to-implement, high-performance and perfusion-ready bioreactors ranging from process development to commercial manufacturing scale,” commented Stefan Schlack, Head of Marketing at SSB.

Christine Gebski, Vice President of Product Management at Repligen, stated, “We are excited to partner with Sartorius Stedim Biotech, a global innovator in bioreactor technology. The integration of our market-leading XCell™ ATF control technology with SSB’s high-performance bioreactors offers a simplified perfusion-enabled bioreactor solution for end users to develop cell culture processes more quickly and implement perfusion more efficiently.”


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

Interphex

Apr 16 2024 New York, USA

Medtec Japan 2024

Apr 17 2024 Tokyo, Japan

FORUMESURE

Apr 22 2024 Marrakech, Morroco

View all events